Clinical Trials Directory

Trials / Completed

CompletedNCT03349242

Natural History Study of Patients With X-linked Retinal Dystrophy Associated With Mutations in Retinitis Pigmentosa GTPase Regulator (RPGR)

Status
Completed
Phase
Study type
Observational
Enrollment
140 (actual)
Sponsor
MeiraGTx UK II Ltd · Industry
Sex
All
Age
5 Years
Healthy volunteers
Not accepted

Summary

The rod-cone dystrophies (often referred to as retinitis pigmentosa (RP)) are a clinically and genetically heterogeneous group of disorders in which there is progressive loss of rod and later cone photoreceptor function leading to severe visual impairment. RP usually occurs as an isolated retinal disorder, but it may also be seen in association with systemic abnormalities.

Detailed description

X-linked Retinitis Pigmentosa (XLRP) is a severe form of RP with early onset of nyctalopia and progression to legal blindness by the 3rd to 4th decade. Most affected males show symptomatic night blindness before the age of 10 years, are often myopic and show fundus abnormalities and ERG changes in early childhood. Examination of close female relatives is helpful in the absence of a family history, as the recognition of the XL carrier state will confirm the diagnosis.

Conditions

Timeline

Start date
2017-12-19
Primary completion
2024-04-19
Completion
2024-04-19
First posted
2017-11-21
Last updated
2024-06-20

Locations

8 sites across 3 countries: United States, Canada, United Kingdom

Source: ClinicalTrials.gov record NCT03349242. Inclusion in this directory is not an endorsement.